Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Additional molecular testing of saliva specimens improves the detection of respiratory viruses.

To KK, Lu L, Yip CC, Poon RW, Fung AM, Cheng A, Lui DH, Ho DT, Hung IF, Chan KH, Yuen KY.

Emerg Microbes Infect. 2017 Jun 7;6(6):e49. doi: 10.1038/emi.2017.35.

2.
3.

Influenza and the use of oseltamivir in children.

Çiftçi E, Karbuz A, Kendirli T.

Turk Pediatri Ars. 2016 Jun 1;51(2):63-71. doi: 10.5152/TurkPediatriArs.2016.2359. eCollection 2016 Jun. Review.

4.

Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014.

Yang Y, Zhang Y, Fang L, Halloran ME, Ma M, Liang S, Kenah E, Britton T, Chen E, Hu J, Tang F, Cao W, Feng Z, Longini IM Jr.

Euro Surveill. 2015 Mar 12;20(10):21056.

5.

Systematic review of influenza A(H1N1)pdm09 virus shedding: duration is affected by severity, but not age.

Fielding JE, Kelly HA, Mercer GN, Glass K.

Influenza Other Respir Viruses. 2014 Mar;8(2):142-50. doi: 10.1111/irv.12216. Epub 2013 Dec 2. Review.

6.
7.

Influenza aerosols in UK hospitals during the H1N1 (2009) pandemic--the risk of aerosol generation during medical procedures.

Thompson KA, Pappachan JV, Bennett AM, Mittal H, Macken S, Dove BK, Nguyen-Van-Tam JS, Copley VR, O'Brien S, Hoffman P, Parks S, Bentley A, Isalska B, Thomson G; EASE Study Consortium.

PLoS One. 2013;8(2):e56278. doi: 10.1371/journal.pone.0056278. Epub 2013 Feb 13.

8.

Comparison of immune response by virus infection and vaccination to 2009 pandemic influenza A/H1N1 in children.

Kang EK, Lim JS, Lee JA, Kim DH.

J Korean Med Sci. 2013 Feb;28(2):274-9. doi: 10.3346/jkms.2013.28.2.274. Epub 2013 Jan 29.

9.

Relationship between respiratory viral load and lung lesion severity: a study in 24 cases of pandemic H1N1 2009 influenza A pneumonia.

Lu PX, Deng YY, Yang GL, Liu WL, Liu YX, Huang H, Wang YX.

J Thorac Dis. 2012 Aug;4(4):377-83. doi: 10.3978/j.issn.2072-1439.2012.08.02.

10.

The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong.

Wu P, Cowling BJ, Wu JT, Lau EH, Ip DK, Nishiura H.

Influenza Other Respir Viruses. 2013 May;7(3):367-82. doi: 10.1111/j.1750-2659.2012.00420.x. Epub 2012 Aug 9. Review.

11.

Viral load at diagnosis and influenza A H1N1 (2009) disease severity in children.

Launes C, Garcia-Garcia JJ, Jordan I, Selva L, Rello J, Muñoz-Almagro C.

Influenza Other Respir Viruses. 2012 Nov;6(6):e89-92. doi: 10.1111/j.1750-2659.2012.00383.x. Epub 2012 May 24.

12.

Two years after pandemic influenza A/2009/H1N1: what have we learned?

Cheng VC, To KK, Tse H, Hung IF, Yuen KY.

Clin Microbiol Rev. 2012 Apr;25(2):223-63. doi: 10.1128/CMR.05012-11. Review.

13.

Effects of influenza antivirals on individual and population immunity over many epidemic waves.

Pepin KM, Riley S, Grenfell BT.

Epidemiol Infect. 2013 Feb;141(2):366-76. doi: 10.1017/S0950268812000477. Epub 2012 Mar 30.

14.

Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10.

Kao CL, Chan TC, Tsai CH, Chu KY, Chuang SF, Lee CC, Li ZR, Wu KW, Chang LY, Shen YH, Huang LM, Lee PI, Yang C, Compans R, Rouse BT, King CC.

PLoS One. 2012;7(2):e31162. doi: 10.1371/journal.pone.0031162. Epub 2012 Feb 6.

15.

The Management of the 2009 pandemic Influenza A H1N1 virus infection.

To KK, Yuen KY.

J Thorac Dis. 2012 Feb;4(1):4-6. doi: 10.3978/j.issn.2072-1439.2011.11.01. No abstract available.

16.

Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients.

Martin-Loeches I, Díaz E, Vidaur L, Torres A, Laborda C, Granada R, Bonastre J, Martín M, Insausti J, Arenzana A, Guerrero JE, Navarrete I, Bermejo-Martin J, Suarez D, Rodriguez A; H1N1 SEMICYUC/REIPI/CIBERES Working group.

Crit Care. 2011;15(6):R286. doi: 10.1186/cc10573. Epub 2011 Nov 28.

17.

Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection.

Sugaya N, Kohno S, Ishibashi T, Wajima T, Takahashi T.

Antimicrob Agents Chemother. 2012 Jan;56(1):369-77. doi: 10.1128/AAC.00132-11. Epub 2011 Oct 24.

18.

Combination chemotherapy for influenza.

Govorkova EA, Webster RG.

Viruses. 2010 Aug;2(8):1510-29. doi: 10.3390/v2081510. Epub 2010 Jul 27.

19.

A validation study comparing the sensitivity and specificity of the new Dr. KSU H1N1 RT-PCR kit with real-time RT-PCR for diagnosing influenza A (H1N1).

Binsaeed AA, Al-Khedhairy AA, Mandil AM, Shaikh SA, Qureshi R, Al-Khattaf AS, Habib HA, Alam AA, Al-Ansary LA, Al-Omran M.

Ann Saudi Med. 2011 Jul-Aug;31(4):351-5. doi: 10.4103/0256-4947.83212.

20.

Viral shedding in patients infected with pandemic influenza A (H1N1) virus in Kenya, 2009.

Waiboci LW, Lebo E, Williamson JM, Mwiti W, Kikwai GK, Njuguna H, Olack B, Breiman RF, Njenga MK, Katz MA.

PLoS One. 2011;6(6):e20320. doi: 10.1371/journal.pone.0020320. Epub 2011 Jun 10.

Supplemental Content

Support Center